Kodiak Sciences (KOD) Net Cash Flow (2017 - 2026)
Kodiak Sciences (KOD) posted Net Cash Flow of -$40.3 million for Q1 2026, down 129.26% on a QoQ basis from $137.8 million in Q4 2025, and down 38.01% year-over-year from -$65.1 million in Q1 2025.
Kodiak Sciences (KOD) Net Cash Flow (2017 - 2026) Analysis & Trends
Kodiak Sciences' Net Cash Flow history runs 10 years deep, the most recent figure standing at -$40.3 million for Q1 2026.
- Quarterly Net Cash Flow fell 38.01% year-over-year to -$40.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $30.7 million (up 128.66% YoY) and the FY2025 annual result came in at $41.8 million, up 135.55% from the prior year.
- Net Cash Flow was -$40.3 million for Q1 2026 at Kodiak Sciences, down from $137.8 million in the prior quarter.
- Across five years, Net Cash Flow topped out at $137.8 million in Q4 2025 and bottomed at -$499.0 million in Q2 2022.
- A 5-year average of -$33.1 million and a median of -$29.8 million in 2024 frame the typical range for Net Cash Flow.
- Annual changes were most pronounced in 2022 — Net Cash Flow plunged 1160.48% — and 2025, when it jumped 562.95%.
- Kodiak Sciences' Net Cash Flow stood at $12.0 million in 2022, then tumbled by 602.22% to -$60.2 million in 2023, then jumped by 50.51% to -$29.8 million in 2024, then soared by 562.95% to $137.8 million in 2025, then sank by 129.26% to -$40.3 million in 2026.
- Business Quant data shows KOD's Net Cash Flow at -$40.3 million in Q1 2026, $137.8 million in Q4 2025, and -$32.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 10.56 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 224.46 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.34 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 457.40 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -152.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 57.19 Mn |
| 10 | Kodiak Sciences | 2.54 Bn | 2.54 Bn | - | -40.33 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -40.33 Mn |
| Mar 31, 2026 | -40.33 Mn |
| Dec 31, 2025 | 137.82 Mn |
| Dec 31, 2025 | 137.82 Mn |
| Sep 30, 2025 | -32.08 Mn |
| Sep 30, 2025 | -32.08 Mn |
| Jun 30, 2025 | -34.74 Mn |
| Jun 30, 2025 | -34.74 Mn |
| Mar 31, 2025 | -29.22 Mn |
| Mar 31, 2025 | -29.22 Mn |
| Dec 31, 2024 | -29.77 Mn |
| Dec 31, 2024 | -29.77 Mn |
| Sep 30, 2024 | -21.35 Mn |
| Sep 30, 2024 | -21.35 Mn |
| Jun 30, 2024 | -26.70 Mn |
| Jun 30, 2024 | -26.70 Mn |
| Mar 31, 2024 | -39.73 Mn |
| Mar 31, 2024 | -39.73 Mn |
| Dec 31, 2023 | -60.16 Mn |
| Dec 31, 2023 | -60.16 Mn |